Summary : Vigabatrin is used to treat babies, one month to two years old with infantile spasms. Zydus has received final approval…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Regulatory
-
-
AgrochemicalsGlobal MarketLaunch
Novo Nordisk launches Anti-Diabetic drug Semaglutide in ‘game-changing’ Pill form
by adminby adminSummary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
-
Global MarketRegulatoryU.S FDA
Swiss drugmaker Idorsia’s insomnia medicine gets US FDA’s approval
by adminby adminSummary : The drug, to be available under the brand name Quviviq, was approved in doses of 25 mg and 50 mg…
-
Global MarketRegulatoryU.S FDA
Glenmark gets US FDA nod for Nasal Spray to treat seasonal Allergic Rhinitis
by adminby adminSynopsis : With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the…
-
RegulatoryU.S FDA
USFDA approval for Marksans Pharma Cetirizine Hydrochloride Tablets
by adminby adminSummary : Marksans Pharma Limited (Reuters: MARK.BO; Bloomberg: MRKS IN; NSE: MARKSANS; BSE: 524404) has received final approval from US Food &…
-
AgrochemicalsGlobal MarketIndiaLaunch
Cadila Pharma expands Oncology Portfolio with Launch of Tarzed
by adminby adminSynopsis : TARZED is considered safe and more efficacious compared to conventional treatment medicines for breast cancer. Cadila Pharmaceuticals Limited on Wednesday…
-
Global MarketRegulatoryU.S FDA
US FDA clears Jubilant Therapeutics’ IND for novel dual LSD1 & HDAC6 inhibitor, JBI-802 for treatment of solid tumours
by adminby adminSynopsis: Jubilant Therapeutics Inc, a biopharmaceutical company, announced US Food and Drug Administration (FDA) clearance of the investigational new drug application (IND)…
-
435 RC meetingCIBRC - Indian Pesticide ApprovalsRC Meeting updates
INDIAN PESTICIDE APPROVAL UPDATES: 435th RC MEETING [CIBRC]
by adminby adminMINUTES OF THE 435th REGISTRATION COMMITTEE MEETING HELD ON 23.12.2021. The 435th meeting of the Registration Committee (RC) was held under the…
-
RegulatoryU.S FDA
US FDA approves expanded MRI compatibility for Abbott’s Proclaim XR Spinal Cord Stimulation System
by adminby adminSummary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…
-
RegulatoryU.S FDA
Xeris Biopharma scores FDA approval for endogenous Cushing’s syndrome drug Recorlev
by adminby adminSynopsis -Ahead of its New Year’s Day decision deadline at the FDA, Xeris Biopharma has snagged an approval for Recorlev, a drug…